Patterns of intracranial glioblastoma recurrence after aggressive surgical resection and adjuvant Management: Retrospective Analysis of 43 Cases

Neurologia Medico-Chirurgica

Volumn 52, Issue 8, 2012, Pages 577-586

  Konishi, Yoshiyuki ^a   Muragaki, Yoshihiro ^a,b   Iseki, Hiroshi ^a,b   Mitsuhashi, Norio ^b   Okada, Yoshikazu ^b  

^a Institute of Advanced Biomedical Engineering and Science   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Glioblastoma; Gross total resection; Progression; Recurrence; Survival

Indexed keywords

AUTOLOGOUS FORMALIN FIXED TUMOR VACCINE; NIMUSTINE; TEMOZOLOMIDE; TUMOR VACCINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; TUMOR GROWTH;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CANCER VACCINES; CHEMORADIOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84865507078     PISSN: 04708105     EISSN: 13498029     Source Type: Journal    
DOI: 10.2176/nmc.52.577     Document Type: Article

References (54)

1. Albert FK, Forsting M, Sartor K, Adams HP, Kunze S: Early postoperative magnetic resonance imaging after resection of malignant glioma: Objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34: 45-61, 1994
2. Brandes AA, Tosoni A, Franceschi E, Sotti G, Frezza G, Amista P, Morandi L, Spagnolli F, Ermani M: Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: Correlation with MGMT promoter methylation status. J Clin Oncol 27: 1275-1279, 2009
3. Chamberlain MC: Radiographic patterns of relapse in glioblastoma. J Neurooncol 101: 319-323, 2011
4. Chan JL, Lee SW, Fraass BA, Normolle DP, Greenberg HS, Junck LR, Gebarski SS, Sandler HM: Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J ClinOncol 20: 1635-1642, 2002
5. The Committee of Brain Tumor Registry of Japan: Report of brain tumor registry of Japan (1984-2000), 12th edition. Neurol Med Chir (Tokyo) 49 Suppl: 1-101, 2009
6. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO, Krisch RE, Nelson DF: Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85: 704-710, 1993
7. Dillman RO, Duma CM, Ellis RA, Cornforth AN, Schiltz PM, Sharp SL, DePriest MC: Intralesional lymphokine-activated killer cells as adjuvant therapy for primary glioblastoma. J Immunother 32: 914-919, 2009
8. Ekinci G, Akpinar IN, Baltacioglu F, Erzen C, Kilic T, Elmaci I, Pamir N: Early-postoperative magnetic resonance imaging in glial tumors: prediction of tumor regrowth and recurrence. Eur J Radiol 45: 99-107, 2003
9. Erickson BJ, Wood CP, Kaufmann TJ, Patriarche JW, Mandrekar J: Optimal presentation modes for detecting brain tumor progression. AJNR Am J Neuroradiol 32: 1652-1657, 2011
10. Fabrini MG, Perrone F, De Franco L, Pasqualetti F, Grespi S, Vannozzi R, Cionini L: Perioperative highdose-rate brachytherapy in the treatment of recurrent malignant gliomas. Strahlenther Onkol 185: 524-529, 2009
11. Forsting M, Albert FK, Kunze S, Adams HP, Zenner D, Sartor K: Extirpation of glioblastomas:MR and CT follow-up of residual tumor and regrowth patterns. AJNR Am J Neuroradiol 14: 77-87, 1993
12. Hochberg FH, Pruitt A: Assumptions in the radiotherapy of glioblastoma. Neurology 30: 907-911, 1980
13. Hou LC, Veeravagu A, Hsu AR, Tse VCK: Recurrent glioblastoma multiforme: a review of natural history and management options. Neurosurg Focus 20(4): E3, 2006
14. Hsieh PC, Chandler JP, Bhangoo S, Panagiotopoulos K, Kalapurakal JA, MarymontMH, Cozzens JW, Levy RM, Salehi S: Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme. Neurosurgery 57: 684-692, 2005
15. Ikuta S, Muragaki Y, Maruyama T, Ogata H, Iseki H: [Assessment of effect and toxicity of temozolomide combined with radiation therapy for newly-diagnosed glioblastoma in Japan]. Tokyo Joshi Ika Daigaku Zasshi 79: 510-515, 2009 (Japanese)
16. Iseki H, Nakamura R, Muragaki Y, Suzuki T, Chernov M, Hori T, Takakura K: Advanced computer-aided intraoperative technologies for information-guided surgical management of gliomas: Tokyo Women's Medical University experience. Minim Invasive Neurosurg 51: 285-291, 2008
17. Iuchi T, Hatano K, Narita Y, Kodama T, Yamaki T, Osato K: Hypofractionated high-dose irradiation for the treatment of malignant astrocytomas using simultaneous integrated boost technique by IMRT. Int J Radiat Oncol Biol Phys 64: 1317-1324, 2006
18. Kondziolka D, Flickinger JC, Bissonette DJ, Bozik M, Lunsford LD: Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. Neurosurgery 41: 776-785, 1997
19. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R: A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95: 190-198, 2001
20. Laperriere N, Zuraw L, Cairncross G: Radiotherapy for newly diagnosed malignant glioma in adults: A systematic review. Radiother Oncol 64: 259-273, 2002
21. Louis DN, Ohgaki H, Wiestler OD, CaveneeWK (eds): WHO Classification of Tumours of the Central Nervous System. Lyon, IARC, 2007
22. Lutz K, Radbruch A, Wiestler B, Baumer P, Wick W, Bendszus M: Neuroradiological response criteria for high-grade gliomas. Clin Neuroradiol 21: 199-205, 2011
23. McDonald MW, Shu HKG, Curran WJ Jr, Crocker IR: Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma. Int J Radiat Oncol Biol Phys 79: 130-136, 2011
24. Mikuni N, Miyamoto S: Surgical treatment of glioma: extent of resection applying functional neurosurgery. Neurol Med Chir (Tokyo) 50: 720-726, 2010
25. Milano MT, Okunieff P, Donatello RS, Mohile NA, Sul J, Walter KA, Korones DN: Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma. Int J Radiat Oncol Biol Phys 78: 1147-1155, 2010
26. Monjazeb AM, Ayala D, Jensen C, Case LD, Bourland JD, Ellis TL, McMullen KP, Chan MD, Tatter SB, Lesser GJ, Shaw EG: A Phase I dose escalation study of hypofractionated IMRT field-in-field boost for newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys 82: 743-748, 2012
27. Muragaki Y, Iseki H, Maruyama T, Kawamata T, Yamane F, Nakamura R, Kubo O, Takakura K, Hori T: Usefulness of intraoperative magnetic resonance imaging for glioma surgery. Acta Neurochir Suppl 98: 67-75, 2006
28. Muragaki Y, Iseki H, Maruyama T, TanakaM, Shinohara C, Suzuki T, Yoshimitsu K, Ikuta S, Hayashi M, Chernov M, Hori T, Okada Y, Takakura K: Information-guided surgical management of gliomas using low-field-strength intraoperative MRI. Acta Neurochir Suppl 109: 67-72, 2011
29. Muragaki Y, Maruyama T, Iseki H, TanakaM, Shinohara C, Takakura K, Tsuboi K, Yamamoto T, Matsumura A, Matsutani M, Karasawa K, Shimada K, Yamaguchi N, Nakazato Y, Sato K, Uemae Y, Ohno T, Okada Y, Hori T: Phase I/IIa trial of autologous formalin-fixed tumor vaccine concomitant with fractionated radiotherapy for newly diagnosed glioblastoma. J Neurosurg 115: 248-255, 2011
30. Muragaki Y, Maruyama T, Nakamura R, Iseki H, Kubo O, Takakura K, Hori T: [Information-guided surgery for glioma removal]. No Shinkei Geka Journal 15: 384-395, 2006 (Japanese)
31. Murakami R, Hirai T, Nakamura H, Furusawa M, Nakaguchi Y, Uetani H, Kitajima M, Yamashita Y: Recurrence patterns of glioblastoma treated with postoperative radiation therapy: relationship between extent of resection and progression-free interval. Jpn J Radiol 30: 193-197, 2012
32. Nagashima T, Matsutani M, Nakamura O, Tanaka Y: [Regrowth pattern of glioblastoma multiforme after radiotherapy]. Gan No Rinsho 35: 1272-1276, 1989 (Japanese)
33. Nakagawa K, Aoki Y, Fujimaki T, Tago M, Terahara A, Karasawa K, Sakata K, Sasaki Y, Matsutani M, Akanuma A: High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 40: 1141-1149, 1998
34. Oh J, Sahgal A, Sanghera P, Tsao MN, Davey P, Lam K, Symons S, Aviv R, Perry JR: Glioblastoma: patterns of recurrence and efficacy of salvage treatments. Can J Neurol Sci 38: 621-625, 2011
35. Oppitz U, Maessen D, Zunterer H, Richter S, Flentje M: 3D-recurrence-patterns of glioblastomas after CTplanned postoperative irradiation. Radiother Oncol 53: 53-57, 1999
36. Pan H, Alksne J, Mundt AJ, Murphy KT, Cornell M, Kesari S, Lawson JD: Patterns of imaging failures in glioblastoma patients treated with chemoradiation: a retrospective study. Med Oncol Epub 2011 Nov 23
37. Paravati AJ, Heron DE, Landsittel D, Flickinger JC, Mintz A, Chen YF, Huq MS: Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: Validation of Radiation Therapy Oncology Group-recursive partitioning analysis in the IMRT and temozolomide era. J Neurooncol 104: 339-349, 2011
38. Proescholdt MA, Macher C, Woertgen C, Brawanski A: Level of evidence in the literature concerning brain tumor resection. Clin Neurol Neurosurg 107: 95-98, 2005
39. Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS: An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115: 3-8, 2011
40. Shibui S: Randomized controlled trial on malignant brain tumors-activities of the Japan Clinical Oncology Group-Brain Tumor Study Group. Neurol Med Chir (Tokyo) 44: 220-221, 2004
41. Shuto T, Matsunaga N, Suinaga J, Yoshizumi T, Tuzuki S, Ootake M: [Role of gamma knife treatment for glioblastoma]. Nippon Kagaku Ryoho Gakkai Zasshi 37: 1024-1026, 2010 (Japanese)
42. Smith MM, Thompson JE, Castillo M, Cush S, Mukherji SK, Miller CH, Quattrocchi KB: MR of recurrent high-grade astrocytomas after intralesional immunotherapy. AJNR Am J Neuroradiol 17: 1065-1071, 1996
43. Sneed PK, Gutin PH, Larson DA, Malec MK, Phillips TL, Prados MD, Scharfen CO, Weaver KA, Wara WM: Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. Int J Radiat Oncol Biol Phys 29: 719-727, 1994
44. Stewart LA: Chemotherapy in adult high-grade glioma: A systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359: 1011-1018, 2002
45. Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, Rohde V, Oppel F, Turowski B, Woiciechowsky C, Franz K, Pietsch T: Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62: 564-576, 2008
46. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO: Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10: 459-466, 2009
47. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005
48. Takakura K, Abe H, Tanaka R, Kitamura K, Miwa T, Takeuchi K, Yamamoto S, Kageyama N, Handa H, Mogami H, Nishimoto A, Uozumi T, Matsutani M, Nomura K: Effects of ACNU and radiotherapy on malignant glioma. J Neurosurg 64: 53-57, 1986
49. Tanaka M, Ino Y, Nakagawa K, Tago M, Todo T: High-dose conformal radiotherapy for supratentorial malignant glioma: A historical comparison. Lancet Oncol 6: 953-960, 2005
50. Tsien C, Moughan J, Michalski JM, Gilbert MR, Purdy J, Simpson J, Kressel JJ, CurranWJ, Diaz A, Mehta MP: Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group trial 98-03. Int J Radiat Oncol Biol Phys 73: 699-708, 2009
51. van den Bent MJ, Carpentier AF, Brandes AA, Sanson M, Taphoorn MJ, Bernsen HJ, Frenay M, Tijssen CC, Grisold W, Sipos L, Haaxma-Reiche H, Kros JM, van Kouwenhoven MC, Vecht CJ, Allqeier A, Lacombe D, Gorlia T: Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organization for Research and Treatment of Cancer phase III trial. J Clin Oncol 24: 2715-2722, 2006
52. Vogelbaum MA, Jost S, Aghi MK, Heimberger AB, Sampson JH, Wen PY, Macdonald DR, Van den Bent M, Chang SM: Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group. Neurosurgery 70: 234-244, 2012
53. Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, Whittle IR, Jaaskelainen J, Ram Z: A Phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 5: 79-88, 2003
54. Wick W, Stupp R, Beule AC, Bromberg J, Wick A, Ernemann U, PlattenM, Marosi C, MasonWP, van den Bent M, Weller M, Rorden C, Karnath HO: A novel tool to analyzeMRI recurrence patterns in glioblastoma. Neuro Oncol 10: 1019-1024, 2008